Cargando…
Activated protein C ameliorates coagulopathy but does not influence outcome in lethal H1N1 influenza: a controlled laboratory study
INTRODUCTION: Influenza accounts for 5 to 10% of community-acquired pneumonias and is a major cause of mortality. Sterile and bacterial lung injuries are associated with procoagulant and inflammatory derangements in the lungs. Activated protein C (APC) is an anticoagulant with anti-inflammatory prop...
Autores principales: | Schouten, Marcel, van der Sluijs, Koenraad F, Gerlitz, Bruce, Grinnell, Brian W, Roelofs, Joris JTH, Levi, Marcel M, van 't Veer, Cornelis, Poll, Tom van der |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2887187/ https://www.ncbi.nlm.nih.gov/pubmed/20398279 http://dx.doi.org/10.1186/cc8964 |
Ejemplares similares
-
Protease-activated receptor-1 impairs host defense in murine pneumococcal pneumonia: a controlled laboratory study
por: Schouten, Marcel, et al.
Publicado: (2012) -
Impact of the factor V Leiden mutation on the outcome of pneumococcal pneumonia: a controlled laboratory study
por: Schouten, Marcel, et al.
Publicado: (2010) -
Feasibility and Safety of Local Treatment with Recombinant Human Tissue Factor Pathway Inhibitor in a Rat Model of Streptococcus pneumoniae Pneumonia
por: van den Boogaard, Florry E., et al.
Publicado: (2015) -
Limited Anti-Inflammatory Role for Interleukin-1 Receptor Like 1 (ST2) in the Host Response to Murine Postinfluenza Pneumococcal Pneumonia
por: Blok, Dana C., et al.
Publicado: (2013) -
Overexpression of activated protein C hampers bacterial dissemination during pneumococcal pneumonia
por: de Boer, Johannes Daan, et al.
Publicado: (2014)